| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Biomarin Pharmaceutical Inc.'s insiders have reduced their positions by a net 17,557 shares worth roughly $1.2M.
Classified under Biotechnology (Health Care sector), BMRN's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 214.6K | $12.03M | - | |
| CFO | 123.3K | $6.91M | - | |
| VP | 84.1K | $4.72M | - | |
| VP | 61.0K | $4.04M | - | |
| Dir | 49.4K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 25, 2023 | Ajer Jeffrey Robert58 | EVP, Chief Commercial Officer | Sale+OE | 49,000 | $115.70 | $5,669,133.50 | -54.4% | -17.6% | -21.4% | |
| Jan 17, 2023 | Bienaime Jean Jacques68 | Chief Executive Officer | Sale+OE | 20,000 | $111.90 | $2,238,000.00 | -5.9% | -10.2% | -16.4% | |
| Jan 13, 2023 | Mueller Brian64 | EVP, Chief Financial Officer | Sale+OE | 2,500 | $114.50 | $286,250.00 | -8.3% | -12.8% | -17.2% | |
| Dec 13, 2022 | Mueller Brian64 | EVP, Chief Financial Officer | Sale+OE | 2,500 | $107.50 | $268,750.00 | -8.3% | -15.9% | -8.0% | |
| Dec 13, 2022 | Bienaime Jean Jacques68 | Chief Executive Officer | Sell | 1,000 | $106.89 | $106,890.00 | -0.3% | -15.9% | -8.0% | |
| Dec 2, 2022 | Mueller Brian64 | EVP, Chief Financial Officer | Sale+OE | 7,001 | $104.50 | $731,604.50 | -20.1% | -5.2% | -12.4% | |
| Dec 2, 2022 | Bienaime Jean Jacques68 | Chief Executive Officer | Sell | 1,500 | $103.98 | $155,967.07 | -0.5% | -5.2% | -12.4% | |
| Nov 23, 2022 | Mueller Brian64 | EVP, Chief Financial Officer | Sale+OE | 5,379 | $98.73 | $531,091.56 | -15.7% | +8.4% | -9.8% | |
| Nov 2, 2022 | Ajer Jeffrey Robert58 | EVP, Chief Commercial Officer | Sell | 3,000 | $86.12 | $258,360.00 | -6.8% | +37.0% | -5.3% | |
| Oct 31, 2022 | Bienaime Jean Jacques68 | Chief Executive Officer | Sell | 1,500 | $86.55 | $129,825.00 | -0.5% | +32.4% | -6.0% |